Company description

Repligen Corporation (RGEN) is a bioprocessing company that specializes in providing products and services to the life sciences industry. Founded in 1981, the company has established itself as a global leader in the production of bioprocessing solutions, offering a variety of products, including chromatography resins, filtration devices, and chromatography systems. With a strong focus on innovation and technology, Repligen has developed cutting-edge products that help biotech and pharmaceutical companies optimize their processes, reduce costs, and improve efficiency. In addition to its product offerings, the company also offers services such as process development and on-site training, further cementing its position as a trusted partner in the bioprocessing industry. With a presence in 35 countries and a highly experienced team, Repligen continues to grow and expand its reach, driven by a commitment to improving human health through the advancement of biotechnology. With a strong financial position and a clear vision for the future, Repligen is poised for success and remains a top choice for investors looking to tap into the growing biotechnology sector.